Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.458 USD | +5.05% | -2.24% | -56.39% |
Apr. 24 | Transcript : Evoke Pharma, Inc. - Special Call | |
Mar. 21 | Evoke Pharma, Inc. Announces Board Changes as of March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 14.08M | Sales 2025 * | 21.9M | Capitalization | 3.88M |
---|---|---|---|---|---|
Net income 2024 * | -3M | Net income 2025 * | 1M | EV / Sales 2024 * | 0.28 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.18 x |
P/E ratio 2024 * |
-1.99
x | P/E ratio 2025 * |
15.3
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.62% |
Latest transcript on Evoke Pharma, Inc.
1 day | +5.05% | ||
1 week | -2.24% | ||
Current month | -24.92% | ||
1 month | -24.26% | ||
3 months | -30.08% | ||
6 months | -60.17% | ||
Current year | -56.39% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 06-12-31 | |
Marilyn Carlson
CTO | Chief Tech/Sci/R&D Officer | 76 | 13-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cam L. Garner
FOU | Founder | 75 | 06-12-31 |
Kenneth Widder
BRD | Director/Board Member | 71 | 07-05-31 |
Todd Brady
BRD | Director/Board Member | 52 | 07-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.458 | +5.05% | 8,747 |
24-04-25 | 0.436 | -2.57% | 15,641 |
24-04-24 | 0.4475 | +0.90% | 9,015 |
24-04-23 | 0.4435 | -2.53% | 4,804 |
24-04-22 | 0.455 | -2.88% | 11,182 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.39% | 3.7M | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- EVOK Stock